Related Experiment Video
Updated: Jun 27, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Association of serum phosphate with vascular and valvular calcification in moderate CKD
Kathryn L Adeney1, David S Siscovick, Joachim H Ix
1University of Washington, Department of Epidemiology, Harborview Medical Center, Seattle, WA 98104, USA.
Insights
Higher serum phosphate levels, even within the normal range, are linked to increased vascular and valvular calcification in individuals with chronic kidney disease (CKD). This suggests phosphate may play a direct role in calcification risk for CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Elevated serum phosphate is a known risk factor for cardiovascular events and mortality in chronic kidney disease (CKD) and normal kidney function populations.
- Experimental data indicates phosphate directly promotes vascular smooth muscle calcification.
Purpose of the Study:
- To investigate the association between serum phosphate concentrations and vascular and valvular calcification in individuals with moderate CKD.
- To determine if normal-range phosphate levels impact calcification prevalence in CKD patients.
Main Methods:
- Analysis of 439 participants from the Multi-Ethnic Study of Atherosclerosis with moderate CKD and no prior cardiovascular disease.
- Measurement of coronary artery, thoracic aorta, aortic valve, and mitral valve calcification using computed tomography.
- Statistical adjustment for demographics, estimated glomerular filtration rate (eGFR), traditional atherosclerosis risk factors, parathyroid hormone, and 1,25-dihydroxyvitamin D levels.
Main Results:
- 95% of participants had serum phosphate concentrations within the normal range (2.5–4.5 mg/dl).
- Increased serum phosphate was significantly associated with higher prevalence of coronary artery (21%), thoracic aorta (33%), and mitral valve (62%) calcification.
- These associations persisted after adjusting for multiple confounding factors, including eGFR and traditional cardiovascular risk factors.
Conclusions:
- Higher serum phosphate concentrations, even within the normal range, are associated with increased vascular and valvular calcification in moderate CKD.
- Phosphate may be an independent risk factor for calcification in CKD.
- Further research is needed to determine if phosphate-lowering therapies can mitigate calcification risk in CKD.
Abstract:
Within the normal range, higher serum phosphate concentrations are associated with cardiovascular events and mortality in individuals with chronic kidney disease (CKD) and in those with normal kidney function. Experimental models suggest that phosphate has a direct calcifying effect on vascular smooth muscle. We examined associations of serum phosphate concentrations with vascular and valvular calcification in 439 participants from the Multi-Ethnic Study of Atherosclerosis who had moderate CKD and no clinical cardiovascular disease. Serum phosphate concentrations were within the normal range (2.5 to 4.5 mg/dl) in 95% of study participants. The prevalence of calcification in the coronary arteries, descending thoracic aorta, aortic valve, and mitral valve was 67, 49, 25, and 20%, respectively, measured by electron-beam or multi-detector row computed tomography. After adjustment for demographics and estimated GFR, each 1-mg/dl increment in serum phosphate concentration was associated with a 21% (P = 0.002), 33% (P = 0.001), 25% (P = 0.16), and 62% (P = 0.007) greater prevalence of coronary artery, thoracic, aortic valve, and mitral valve calcification, respectively. Adjustment for traditional risk factors for atherosclerosis, parathyroid hormone, or 1,25-dihydroxyvitamin D levels did not alter these associations. In conclusion, higher serum phosphate concentrations, although still within the normal range, are associated with a greater prevalence of vascular and valvular calcification in people with moderate CKD. It remains to be determined whether lowering phosphate concentrations will impact calcification risk in the setting of kidney disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Skeleton and Calcium Homeostasis

